SCHEMBL8957360

SCHEMBL8957360

COc1ccc(CCCO[N+](=O)[O-])cc1

nearest known ligand 0.66

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.50
KCNJ1 P48048 1/20 0.48
KCNH2 Q12809 1/20 0.48
ALOX5 P09917 1/20 0.46
TAAR1 Q96RJ0 1/20 0.46
CA12 O43570 3/20 0.45
CA1 P00915 3/20 0.45
CA2 P00918 3/20 0.45
CA4 P22748 3/20 0.45
CA9 Q16790 3/20 0.45
IGF1R P08069 1/20 0.45
ALOX15 P16050 1/20 0.45
TDP1 Q9NUW8 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
RAB9A P51151 2/20 0.44
MAPT P10636 1/20 0.44
NPC1 O15118 1/20 0.44
F2RL1 P55085 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13737590 0.86 CALM1 (0.53) CALM1ALOX5TAAR1IGF1RALOX15
SCHEMBL7051536 0.79 KCNJ1 (0.54) CALM1KCNJ1KCNH2ALOX5TAAR1
SCHEMBL8957375 0.79 ESR1 (0.45) CALM1TAAR1CA12CA1CA2
SCHEMBL8957396 0.79 IDO1 (0.52) CA12CA1CA2CA4CA9
SCHEMBL13396320 0.79 ALDH1A1 (0.43) CA12CA1CA2CA4CA9
SCHEMBL8957335 0.77 SMN1; SMN2 (0.58) CA12CA1CA2CA4CA9
SCHEMBL3022392 0.77 MAPT (0.41) KCNH2CA12CA1CA2CA4
Nitric Acid SCHEMBL9874342 0.77 CALM1 (0.54) CALM1KCNJ1KCNH2ALOX5TAAR1
SCHEMBL11740096 0.76 CALM1 (0.62) CALM1ALOX5TAAR1CA12CA1
SCHEMBL10595320 0.76 POLB (0.46) CA12CA1CA2CA4CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0689435-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1996-01-03 EP claimed
WO-1994021248-A1 USE OF SUBSTITUTED ALKYL NITRATES FOR THE TREATMENT OF PATHOLOGICALLY INCREASED INTRA-OCULAR PRESSURE BYK NEDERLAND BV (NL) 1994-09-29 WO claimed
WO-2012152438-A1 PROCESS FOR THE PREPARATION OF NITRATE ACID ESTER OF ORGANIC COMPOUNDS NICOX S.A. (FR) 2012-11-15 WO disclosed
US-5049694-A Cardiovascular disorders CEDONA PHARMACEUTICALS B.V. (NL) 1991-09-17 US disclosed
EP-0359335-A2 Pharmaceutical composition having relaxing activity which contains a nitrate ester as active substance CEDONA PHARMACEUTICALS B.V. (NL) 1990-03-21 EP disclosed